Cardiovascular Therapeutics: 2022, vol: 2022, issue:
- 1)- Kexin Wen, Yongqing Huang, Qi Guo, Tao Wu, Juanzhang Liu, Yuping Zheng, Shuxian Zhou, Dengfeng Geng. Predicting Risk Factors of Acute Kidney Injury in the First 7 Days after Admission: Analysis of a Group of Critically Ill Patients. Cardiovascular therapeutics. 2022, 2022: 1407563
Cited : 3Read More - 2)- Raquel Chiles, Rami A Al-Horani. Vericiguat: A New Hope for Heart Failure Patients. Cardiovascular therapeutics. 2022, 2022: 1554875Cited : 6Read More
- 3)- Sheng Wang, Zhaoyun Cheng, Xianjie Chen, Guoqing Lu, Xiliang Zhu, Gaojun Xu. Long Noncoding RNA SNHG4 Attenuates the Injury of Myocardial Infarction via Regulating miR-148b-3p/DUSP1 Axis. Cardiovascular therapeutics. 2022, 2022: 1652315Cited : 5Read More
- 4)- Ruibin Wei, Yingqing Feng. Noncoding RNA in the Regulation of Acute Aortic Dissection: From Profile to Mechanism. Cardiovascular therapeutics. 2022, 2022: 2371401Cited : 3Read More
- 5)- Lihua Zou, Ruquan Han. Inflammatory Response and Immune Regulation in Brain-Heart Interaction after Stroke. Cardiovascular therapeutics. 2022, 2022: 2406122Cited : 7Read More
- 6)- Wanwen Kong, Junyi Ma, Ying Lin, Weiyu Chen. Positive Association of Plasma Trimethylamine-N-Oxide and Atherosclerosis in Patient with Acute Coronary Syndrome. Cardiovascular therapeutics. 2022, 2022: 2484018Cited : 3Read More
- 7)- Keqin Chen, Changmiao Hou, Lei Xu, Hanwu Peng, Chaogui He, Jing Liu, Guoqing Wang, Shaoshuai Huang, Xiehong Liu. HSPB1 Regulates Autophagy and Apoptosis in Vascular Smooth Muscle Cells in Arteriosclerosis Obliterans. Cardiovascular therapeutics. 2022, 2022: 3889419Cited : 3Read More
- 8)- Yanli Wang, Qiaomin Wu, Jinfeng Liu, Ruxiu Liu. The Effect of the Tongyang Huoxue Recipe (TYHX) on the / in Ischemia/Reperfusion Sinoatrial Node Cells. Cardiovascular therapeutics. 2022, 2022: 4114817Cited : 3Read More
- 9)- Zhenhua Wu, Yunpeng Bai, Yujuan Qi, Chao Chang, Yan Jiao, Yaobang Bai, Zhigang Guo. lncRNA NEAT1 Downregulation Ameliorates the Myocardial Infarction of Mice by Regulating the miR-582-5p/F2RL2 Axis. Cardiovascular therapeutics. 2022, 2022: 4481360Cited : 8Read More
- 10)- Tongfeng Chen, Yuhao Liu, Jing Zhang, Zirui Sun, Jiangtao Cheng, Yu Han, Chuanyu Gao. Comparison between Cardiac CTA and Echocardiography for Assessment of Ventricular Septal Rupture Diameter and Its Effect on Transcatheter Closure. Cardiovascular therapeutics. 2022, 2022: 5011286Cited : 0Read More
- 11)- Jin Yu, Jeongmin Lee, Seung-Hwan Lee, Jae-Hyung Cho, Hun-Sung Kim. A Study on Weight Loss Cause as per the Side Effect of Liraglutide. Cardiovascular therapeutics. 2022, 2022: 5201684Cited : 2Read More
- 12)- Jing Li, Sanbao Chen, Sicong Ma, Mingque Yang, Zizhao Qi, Kun Na, Miaohan Qiu, Yi Li, Yaling Han. Safety and Efficacy of Bivalirudin versus Unfractionated Heparin Monotherapy in Patients with CAD and DM Undergoing PCI: A Retrospective Observational Study. Cardiovascular therapeutics. 2022, 2022: 5352087Cited : 5Read More
- 13)- Yue Hu, Xiaotong Wang, Shengjue Xiao, Na Sun, Chunyan Huan, Huimin Wu, Minjia Guo, Tao Xu, Defeng Pan. A Clinical Nomogram Based on the Triglyceride-Glucose Index to Predict Contrast-Induced Acute Kidney Injury after Percutaneous Intervention in Patients with Acute Coronary Syndrome with Diabetes Mellitus. Cardiovascular therapeutics. 2022, 2022: 5443880Cited : 4Read More
- 14)- Mosayeb Soleymani, Farzad Masoudkabir, Mahsima Shabani, Ali Vasheghani-Farahani, Amir Hossein Behnoush, Amirmohammad Khalaji. Updates on Pharmacologic Management of Microvascular Angina. Cardiovascular therapeutics. 2022, 2022: 6080258Cited : 6Read More
- 15)- Guangxin Cao, Hua Zhou, Dong Wang, Lei Xu. Knockdown of lncRNA XIST Ameliorates IL-1-Induced Apoptosis of HUVECs and Change of Tissue Factor Level via miR-103a-3p/HMGB1 Axis in Deep Venous Thrombosis by Regulating the ROS/NF-B Signaling Pathway. Cardiovascular therapeutics. 2022, 2022: 6256384Cited : 11Read More
- 16)- Dan Xu, Ankith Nair, Charlie Sigston, Chau Ho, Jia Li, Daya Yang, Xinxue Liao, Wei Chen, Ming Kuang, Yanbing Li, Christopher Reid, Haipeng Xiao. Potential Roles of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs) in Nondiabetic Populations. Cardiovascular therapeutics. 2022, 2022: 6820377Cited : 13Read More
- 17)- Armin Attar, Arman Karimi Behnagh, Mehrasa Hosseini, Foad Amanollahi, Paria Shafiekhani, Ali Kabir. Beta-Blockers for Primary Prevention of Anthracycline-Induced Cardiac Toxicity: An Updated Meta-Analysis of Randomized Clinical Trials. Cardiovascular therapeutics. 2022, 2022: 8367444Cited : 2Read More
